Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, Inc. (ETON), bought 34,940 shares at $6.00 ($60K) on 2018-11-15, disclosed to the SEC on 2018-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 24,940 | $0 | 0.0% |
| 2 | $6.00 | 10,000 | $60K | 100.0% |
| Total | $1.72 avg | 34,940 | $60K | 100% |
| Filing → |
| ETON | SELL | 2025-06-05 | $4.8M | — | Filing → |
| ETON | BUY | 2022-09-23 | $21K | — | Filing → |
| ETON | BUY | 2021-08-20 | $43K | — | Filing → |